![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Founded
Website
Sector
KANDO id: 125069
Company type
Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.Funding rounds
Acquisition USD 8,300,000,000
USD 8,300,000,000 ( ) at USD 8,300,000,000 pre-money valuation
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Roche Holding AG | USD 8,300,000,000 (USD 8,300,000,000) Initial investment. Led the round. |
| Investor | Profile | Country | |
|---|---|---|---|
|
Alta Partners LP | Venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies. |
| Investor | Profile | Country | |
|---|---|---|---|
|
Charter Venture Capital (Charter Ventures), (Charter Life Sciences Venture Capital) | Venture capital firm |
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
| Investor | Profile | Country | |
|---|---|---|---|
|
Genentech Inc | Discovery, development, commercialization and manufacturing of biotherapeutics by using human genetic information |
Investment activity status
Active investor